Enovix CorporationENVXNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank74
3Y CAGR-85.5%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-85.5%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 202540.99%
Q3 20256.99%
Q2 202546.49%
Q1 2025-47.54%
Q4 2024125.09%
Q3 202414.57%
Q2 2024-28.53%
Q1 2024-28.57%
Q4 20233590.50%
Q4 2023376.19%
Q3 2023100.00%
Q2 2023-98.08%
Q4 202213562.50%
Q4 2022-99.84%
Q3 20220.00%
Q2 20220.00%
Q4 20210.00%
Q4 20210.00%
Q2 20210.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%